Press release
TurboGen Advances in the American Market: Signs LOI for System Installation with New US Client
Yaron Gilboa, CEO of TurboGen: "The signing of this LOI marks another significant milestone in our global expansion. The growing demand for efficient and sustainable energy solutions in the US market underscores the need for TurboGen's technology. We believe that our 'Energy as a Service' model will allow customers to benefit from our technology while reducing costs and increasing energy efficiency."
This announcement follows a number of TurboGen's recent successes, including the first installation of a commercial system in New York City and the completion of successful trials at Technion laboratories, confirming the hydrogen combustion capabilities of the company's systems.
About TurboGen:
TurboGen (TASE: TURB) specializes in developing advanced solutions for local energy production in buildings and various facilities. The company's innovative technology is designed to provide efficient, reliable, and environmentally friendly energy solutions, addressing the growing global demand for distributed electricity generation.
For more information about the company: https://turbogenchp.com
This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.
Media Contact
Company Name: TurboGen
Contact Person: Investor Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=turbogen-advances-in-the-american-market-signs-loi-for-system-installation-with-new-us-client]
City: Petah Tikva
Country: Israel
Website: http://turbogenchp.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release TurboGen Advances in the American Market: Signs LOI for System Installation with New US Client here
News-ID: 3645346 • Views: …
More Releases from ABNewswire
EGFR Inhibitor Market Expected to Gain Momentum Through 2034, According to Delve …
The Key EGFR Inhibitor Companies in the market include - Merus, Cullinan Oncology/Taiho Pharma, Suzhou Puhe Pharmaceutical, TWi Biotechnology, and others.
DelveInsight's "EGFR Inhibitor Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the EGFR Inhibitor, historical and forecasted epidemiology as well as the EGFR Inhibitor market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the EGFR…
How to Fight Food Waste in Canada: Lessons from Ugly Potato Day
Over 490,000 pounds of food were saved from waste this year. See how to turn food waste into hope.
Cloverdale, BC - October 20, 2025 - Food waste is one of the biggest challenges facing Canada today. Every year, millions of pounds of perfectly edible food end up in landfills, often because of strict cosmetic standards or poor storage habits at home. Not only does this waste contribute to greenhouse gas…
Epidermolysis Bullosa Market Dynamics Indicate Upward Trajectory Through 2034, R …
The Key Epidermolysis Bullosa Companies in the market include - Berg Pharma, Holostem Terapie Avanzate, Aegle Therapeutics, RegeneRx Biopharmaceuticals, BridgeBio Pharma, InMed Pharmaceuticals, Fibrocell Science, Krystal Biotech, and others.
The Epidermolysis Bullosa market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Epidermolysis Bullosa pipeline products will significantly revolutionize the Epidermolysis Bullosa market dynamics.
DelveInsight's "Epidermolysis Bullosa Market Insights, Epidemiology, and…
Kolega.ai Launches Autonomous AI Software Engineer, Achieves Breakeven Status wi …
Kolega.ai emerges from stealth with a new category of AI developer, an Autonomous Agent for Enterprise Software Engineering. The company announces it has achieved breakeven status and secured significant multi-year revenue commitments, signaling a new era of capital-efficient AI innovation.
JERSEY, CHANNEL ISLANDS - Kolega.ai today announced its official launch, unveiling an Autonomous Agent for Software Engineering capable of executing the entire software development lifecycle (SDLC) from simple well structured requirements.…
More Releases for TurboGen
TurboGen Collaborates on Developing a Mobile Energy Production System for the De …
TurboGen's entry into the defense industry highlights the technological relevance of its innovative solutions.
November 19, 2024 - TurboGen (TASE: TURB) (OTCPK: TURG.F), a leader in developing advanced innovative solutions for local energy production, is pleased to announce [https://www.linkedin.com/feed/update/urn:li:activity:7264610147996454916] the signing of a Memorandum of Understanding (MOU) with a leading Israeli defense company. The agreement, signed on November 19th 2024, focuses on integrating TurboGen's cutting-edge technology into a portable energy production…
TurboGen Advances in the European Market: Signs LOI for System Installation with …
This agreement represents a significant step in TurboGen's expansion into the European market and the German Market specifically, and in advancing TurboGen's innovative "Energy as a Service" model.
November 11, 2024 - TurboGen (TASE: TURB) (OTCPK: TURG.F), a leader in developing advanced innovative solutions for local energy production, is pleased to announce [https://turbogenchp.com/wp-content/uploads/2024/11/%D7%98%D7%95%D7%A8%D7%91%D7%95%D7%92%D7%9F-%D7%9E%D7%95%D7%A0%D7%92%D7%A9.pdf] today that it has entered into a Letter of Intent (LOI) with the Gemran Company 'IP Innovative Power…
Following its first commercial success, Groundbreaking trials at Technion Labora …
Petah Tikva, Israel - May 27th, 2024 - TurboGen (TASE: TURB), a leading developer of multi-fuel hybrid micro-turbines, is thrilled to announce that following the successful deployment of its first commercial installation, a series of groundbreaking tests conducted at the Technion Institute of Technology have provided scientific validation of the company's TG40 system's ability to operate efficiently and with high performance on hydrogen-methane fuel blends.
The trials, conducted under the supervision…
TurboGen Achieves Breakthrough with First Commercial System Now Operating in New …
PETAH TIKVA, Israel - May 08, 2024 - TurboGen (TASE: TURB), a leading developer of advanced solutions for on-site energy generation in residential buildings, Nursery Home, Hotels and facilities, today announced a significant milestone with the successful installation and commissioning of its first commercial system at a customer site in New York City. The groundbreaking TG40 system has been successfully integrated into the multi-story building's infrastructure, providing electricity and heat…
Industry Update: Fueling the Future - Israel's Hydrogen Ecosystem and the Path t …
As the world strides toward a greener future, Israel's hydrogen ecosystem is setting the stage for a monumental shift in global energy paradigms, with companies like TurboGen at the forefront, revolutionizing how we harness and utilize hydrogen power.
In the global race towards a sustainable future, Israel emerges as a frontrunner, charting a course through the uncharted waters of hydrogen innovation. The nation's unique blend of cutting-edge research, robust government support,…
